Form 4: Compass Pathways Director Ekaterina Malievskaia Executes Stock Sales Under 10b5-1 Plan

Ekaterina Malievskaia, a director at Compass Pathways plc, sold shares of the company's ordinary stock on March 12th and 13th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Ekaterina Malievskaia, a director of Compass Pathways plc, executed sales of the company's ordinary shares on March 12 and March 13, 2024.
• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on August 23, 2023.
• On March 12, 2024, 15,740 shares were sold at a weighted average price of $10.5803, with individual prices ranging from $10.36 to $10.765.
• On March 13, 2024, 17,203 shares were sold at a weighted average price of $10.8049, with individual prices ranging from $10.65 to $11.07.
• Following these transactions, Dr. Malievskaia directly owns 4,059,630 shares and indirectly owns 4,061,904 shares through her spouse, George Jay Goldsmith.
• Dr. Malievskaia and Mr. Goldsmith disclaim beneficial ownership of each other's shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock sales by a company director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.

Industry Context

Sales by company insiders are routinely monitored by investors. Sales under 10b5-1 plans are generally viewed as less impactful than discretionary sales, as they are pre-planned.

Stakeholder Impact

• Shareholders may be interested in the insider selling activity, although the pre-planned nature of the sales mitigates potential concerns.
• The sales could exert downward pressure on the stock price, although the impact is likely to be limited due to the relatively small volume of shares sold compared to the total outstanding.

Key Dates